Figure. Proportion of Medicaid Managed Care Plans (MCP) in State Covering at Least 1 Generic Injectable or Generic or Brand Intranasal Naloxone Formulation Without Any Restrictions (IMAGE)

Boston University School of Public Health

Figure. Proportion of Medicaid Managed Care Plans (MCP) in State Covering at Least 1 Generic Injectable or Generic or Brand Intranasal Naloxone Formulation Without Any Restrictions

Caption

Figure illustrates the proportion of Medicaid managed care plans (MCP) in state covering at least one generic injectable or generic or brand intranasal naloxone formulation without any restrictions. The crosshatch pattern indicates the state had an opioid overdose death rate per 100, 000 people in the 75th percentile or above (32.5%).

Credit

Boston University School of Public Health

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.